HopeStage
Back to all studies
CompletedNCT00538642

Switching to ziprasidone to improve diabetes risk in schizophrenia or bipolarity

About this titleRead the official source — NCT00538642
Medication studyAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
San AntonioSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2007
Recruitment status
Completed
Enrollment listed in the registry
24
Sponsor
The University of Texas Health Science Center at San Antonio
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT00538642
Official title
Show the full official title

Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

San Antonio

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is The University of Texas Health Science Center at San Antonio, a university.

Did this study involve medication?

Yes. The study involved medication, including ziprasidone.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies